Phosphate homeostasis and the renal-gastrointestinal axis

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 2, 2010, Pages

  Marks, Joanne ^a   Debnam, Edward S ^a   Unwin, Robert J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Kidney; Phosphate transport; Phosphatonins; Proximal tubule; Small intestine

Indexed keywords

PHOSPHATE; SODIUM ION; SODIUM PHOSPHATE COTRANSPORTER;

DUODENUM; HUMAN; HYPERPHOSPHATEMIA; ILEUM; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; JEJUNUM; KIDNEY FAILURE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; NONHUMAN; PHOSPHATE EXCRETION; PHOSPHATE INTAKE; PHOSPHATE METABOLISM; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; REVIEW; TRANSPORT KINETICS;

EID: 77955362086     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00508.2009     Document Type: Review

References (148)

1. Abe M, Matsumoto K. Perforation of small intestine diverticulum in a maintenance hemodialysis patient. Clin Nephrol 69: 457-460, 2008. (Pubitemid 351803489)
2. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20: 381-387, 2009.
3. Albaaj F, Hutchison A. Hyperphosphataemia in renal failure: causes, consequences and current management. Drugs 63: 577-596, 2003.
4. Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2: 136-148, 2006.
5. i cotransporter during ontogeny. Am J Physiol Gastrointest Liver Physiol 283: G426-G434, 2002.
6. +/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. Kidney Int 69: 495-503, 2006.
7. Bai L, Collins JF, Ghishan FK. Cloning and characterization of a type III Na-dependent phosphate cotransporter from mouse intestine. Am J Physiol Cell Physiol 279: C1135-C1143, 2000.
8. Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 95: 5372-5377, 1998.
9. Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, bu-Zahra H, Frappier D, Burkett K, Carpenter TO, Anderson D, Garabedian M, Sermet I, Fujiwara TM, Morgan K, Tenenhouse HS, Juppner H. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodiumphosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78: 179-192, 2006.
10. Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, Jan De Beur SM, Schiavi SC, Kumar R. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest 112: 785-794, 2003. (Pubitemid 38057719)
11. Berndt T, Kumar R. Phosphatonins and the regulation of phosphate homeostasis. Annu Rev Physiol 69: 341-359, 2007.
12. Berndt T, Thomas LF, Craig TA, Sommer S, Li X, Bergstralh EJ, Kumar R. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci USA 104: 11085-11090, 2007.
13. Berndt TJ, Craig TA, McCormick DJ, Lanske B, Sitara D, Razzaque MS, Pragnell M, Bowe AE, O'Brien SP, Schiavi SC, Kumar R. Biological activity of FGF-23 fragments. Pflügers Arch 454: 615-623, 2007.
14. Berner W, Kinne R, Murer H. Phosphate transport into brush-border membrane vesicles isolated from rat small intestine. Biochem J 160: 467-474, 1976.
15. Biber J, Hernando N, Forster I, Murer H. Regulation of phosphate transport in proximal tubules. Pflügers Arch 458: 39-52, 2009.
16. Bielesz B, Klaushofer K, Oberbauer R. Renal phosphate loss in hereditary and acquired disorders of bone mineralization. Bone 35: 1229-1239, 2004. (Pubitemid 40260388)
17. Bikle DD, Munson S. The villus gradient of brush border membrane calmodulin and the calcium-independent calmodulin-binding protein parallels that of calcium-accumulating ability. Endocrinology 118: 727-732, 1986.
18. Borowitz SM, Ghishan FK. Maturation of jejunal phosphate transport by rat brush border membrane vesicles. Pediatr Res 19: 1308-1312, 1985.
19. Borowitz SM, Ghishan FK. Phosphate transport in human jejunal brush-border membrane vesicles. Gastroenterology 96: 4-10, 1989.
20. Borowitz SM, Granrud GS. Glucocorticoids inhibit intestinal phosphate absorption in developing rabbits. J Nutr 122: 1273-1279, 1992.
21. Borowitz SM, Granrud GS. Ontogeny of intestinal phosphate absorption in rabbits. Am J Physiol Gastrointest Liver Physiol 262: G847-G853, 1992.
22. Breusegem SY, Takahashi H, Giral-Arnal H, Wang X, Jiang T, Verlander JW, Wilson P, Miyazaki-Anzai S, Sutherland E, Caldas Y, Blaine JT, Segawa H, Miyamoto K, Barry NP, Levi M. Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiency. Am J Physiol Renal Physiol 297: F350-F361, 2009.
23. Brooks DP, Ali SM, Contino LC, Stack E, Fredrickson TA, Feild J, Edwards RM. Phosphate excretion and phosphate transporter messenger RNA in uremic rats treated with phosphonoformic acid. J Pharmacol Exp Ther 281: 1440-1445, 1997.
24. i diet of type II NaPi cotransporters in vitamin D receptor- and 1αOHase-deficient mice. Am J Physiol Cell Physiol 288: C429-C434, 2005.
25. Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R. Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 90: 1012-1020, 2005. (Pubitemid 40279227)
26. Collins JF, Bai L, Ghishan FK. The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors. Pflügers Arch 447: 647-652, 2004.
27. i) transporter in the control and hypophosphatemic mouse. FASEB J 8: 862-868, 1994.
28. Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H, Yildirim Z, Gocmen A, Tolun A. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 79: 650-656, 2006.
29. i cotransport in rat kidney: localization by RT-PCR and immunohistochemistry. Am J Physiol Renal Fluid Electrolyte Physiol 266: F767-F774, 1994.
30. Danisi G, Murer H. Inorganic phosphate absorption in small intestine. In: Handbook of Physiology. The Gastrointestinal System. Intestinal Absorption and Secretion. Bethesda, MD: Am Physiol Soc, 1991, sect. 6, vol. IV, chapt. 12, p. 323-336.
31. Danisi G, Bonjour JP, Straub RW. Regulation of Na-dependent phosphate influx across the mucosal border of duodenum by 1,25-dihydroxycholecalciferol. Pflügers Arch 388: 227-232, 1980.
32. Danisi G, Caverzasio J, Trechsel U, Bonjour JP, Straub RW. Phosphate transport adaptation in rat jejunum and plasma level of 1,25-dihydroxyvitamin D3. Scand J Gastroenterol 25: 210-215, 1990.
33. Debnam ES, Smith MW, Sharp PA, Srai SK, Turvey A, Keable SJ. The effects of streptozotocin diabetes on sodium-glucose transporter (SGLT1) expression and function in rat jejunal and ileal villus-attached enterocytes. Pflügers Arch 430: 151-159, 1995.
34. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167: 879-885, 2007. (Pubitemid 46762749)
35. DuBose TD Jr, Pucacco LR, Seldin DW, Carter NW, Kokko JP. Microelectrode determination of pH and PCO2 in rat proximal tubule after benzolamide: evidence for hydrogen ion secretion. Kidney Int 15: 624-629, 1979.
36. i). Pflügers Arch 449: 265-270, 2004.
37. Eto N, Miyata Y, Ohno H, Yamashita T. Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodiumdependent phosphate transporter in rats with adenine-induced renal failure. Nephrol Dial Transplant 20: 1378-1384, 2005.
38. Eto N, Tomita M, Hayashi M. NaPi-mediated transcellular permeation is the dominant route in intestinal inorganic phosphate absorption in rats. Drug Metab Pharmacokinet 21: 217-221, 2006.
39. Farrow EG, Davis SI, Summers LJ, White KE. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 20: 955-960, 2009.
40. Fassbender WJ, Brandenburg V, Schmitz S, Sandig D, Simon SA, Windolf J, Stumpf UC. Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients. Clin Lab 55: 144-152, 2009.
41. Finn WF. Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients. Clin Nephrol 65: 191-202, 2006.
42. Forster IC, Hernando N, Biber J, Murer H. Proximal tubular handling of phosphate: a molecular perspective. Kidney Int 70: 1548-1559, 2006.
43. i cotransporter. J Membr Biol 212: 177-190, 2006.
44. 3-induced intestinal absorption of calcium and phosphorus in rats. Miner Electrolyte Metab 12: 213-217, 1986.
45. Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, Baum M. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 297: F282-F291, 2009.
46. Giral H, Caldas Y, Sutherland E, Wilson P, Breusegem SY, Barry N, Blaine J, Jiang T, Wang XX, Levi M. Regulation of the rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol 297: F1466-F1475, 2009.
47. Goetz R, Nakada Y, Hu MC, Kurosu H, Wang L, Nakatani T, Shi M, Eliseenkova AV, Razzaque MS, Moe OW, Kuro-o M, Mohammadi M. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci USA 107: 407-412, 2010.
48. Gottschalk CW, Lassiter WE, Mylle M. Localization of urine acidification in the mammalian kidney. Am J Physiol 198: 581-585, 1960.
49. i type IIb cotransporter by dietary phosphate intake. Am J Physiol Gastrointest Liver Physiol 277: G756-G762, 1999.
50. Haussler MR, Baylink DJ, Hughes MR, Brumbaugh PF, Wergedal JE, Shen FH, Nielsen RL, Counts SJ, Bursac KM, McCain TA. The assay of 1alpha,25- dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol (Oxf) 5 Suppl: 151S-165S, 1976.
51. Hilfiker H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA 95: 14564-14569, 1998. (Pubitemid 28549407)
52. Hu MC, Shi M, Zhang J, Pastor J, Lanske B, Razzaque MS, Rosenblatt KP, Baum M, Kuro-o M, Moe OW. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010. Epub ahead of print.
53. Imanishi Y, Koyama H, Inaba M, Okuno S, Nishizawa Y, Morii H, Otani S. Phosphorus intake regulates intestinal function and polyamine metabolism in uremia. Kidney Int 49: 499-505, 1996.
54. Indridason OS, Quarles LD. Hyperphosphatemia in end-stage renal disease. Adv Ren Replace Ther 9: 184-192, 2002.
55. Inoue Y, Segawa H, Kaneko I, Yamanaka S, Kusano K, Kawakami E, Furutani J, Ito M, Kuwahata M, Saito H, Fukushima N, Kato S, Kanayama HO, Miyamoto K. Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J 390: 325-331, 2005.
56. Jaureguiberry G, Carpenter TO, Forman S, Juppner H, Bergwitz C. A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc. Am J Physiol Renal Physiol 295: F371-F379, 2008.
57. 3. Biochem J 343: 705-712, 1999.
58. Katai K, Tanaka H, Tatsumi S, Fukunaga Y, Genjida K, Morita K, Kuboyama N, Suzuki T, Akiba T, Miyamoto K, Takeda E. Nicotin-amide inhibits sodium-dependent phosphate cotransport activity in rat small intestine. Nephrol Dial Transplant 14: 1195-1201, 1999.
59. Kempson SA, Lotscher M, Kaissling B, Biber J, Murer H, Levi M. Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules. Am J Physiol Renal Fluid Electrolyte Physiol 268: F784-F791, 1995.
60. Kiela PR, Ghishan FK. Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis. Lab Invest 89: 7-14, 2009.
61. Kirchner S, Muduli A, Casirola D, Prum K, Douard V, Ferraris RP. Luminal fructose inhibits rat intestinal sodium-phosphate cotransporter gene expression and phosphate uptake. Am J Clin Nutr 87: 1028-1038, 2008. (Pubitemid 351549250)
62. Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, Sugimura K, Kishimoto T, Kinoshita S, Kuroki T, Nabeshima Y. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 280: 1015-1020, 2001.
63. Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K, Tominaga Y, Otsuki N, Nibu K, Nakagawa K, Tsugawa N, Okano T, Kitazawa R, Fukagawa M. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 77: 232-238, 2010.
64. Kuro-o M. Klotho. Pflügers Arch 459: 333-343, 2010.
65. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281: 6120-6123, 2006.
66. Lapointe JY, Tessier J, Paquette Y, Wallendorff B, Coady MJ, Pichette V, Bonnardeaux A. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int 69: 2261-2267, 2006.
67. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64: 2272-2279, 2003.
68. 3. Am J Physiol Gastrointest Liver Physiol 251: G90-G95, 1986.
69. Leung JC, Barac-Nieto M, Hering-Smith K, Silverstein DM. Expression of the rat renal PiT-2 phosphate transporter. Horm Metab Res 37: 265-269, 2005.
70. Locatelli F, Cannata-Andia JB, Drueke TB, Horl WH, Fouque D, Heimburger O, Ritz E. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 17: 723-731, 2002.
71. Loghman-Adham M. Safety of new phosphate binders for chronic renal failure. Drug Saf 26: 1093-1115, 2003. (Pubitemid 38021391)
72. Loghman-Adham M. Phosphate binders for control of phosphate retention in chronic renal failure. Pediatr Nephrol 13: 701-708, 1999.
73. i transport adaptation to low phosphorus diet in uremic rats. J Am Soc Nephrol 3: 1930-1937, 1993.
74. i transport. Am J Physiol Renal Fluid Electrolyte Physiol 265: F756-F763, 1993.
75. Loghman-Adham M, Motock GT. Use of phosphonoformic acid to induce phosphaturia in chronic renal failure in rats. Ren Fail 18: 855-866, 1996. (Pubitemid 26399124)
76. Loghman-Adham M, Szczepanska-Konkel M, Dousa TP. Phosphate transport in brush border membranes from uremic rats. Response to phosphonoformic acid. J Am Soc Nephrol 3: 1253-1259, 1992.
77. Magen D, Berger L, Coady MJ, Ilivitzki A, Militianu D, Tieder M, Selig S, Lapointe JY, Zelikovic I, Skorecki K. A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N Engl J Med 362: 1102-1109, 2010.
78. Marks J, Churchill LJ, Debnam ES, Unwin RJ. Matrix extracellular phosphoglycoprotein inhibits phosphate transport. J Am Soc Nephrol 19: 2313-2320, 2008.
79. Marks J, Churchill LJ, Srai SK, Biber J, Murer H, Jaeger P, Debnam ES, Unwin RJ. Intestinal phosphate absorption in a model of chronic renal failure. Kidney Int 72: 166-173, 2007.
80. Marks J, Srai SK, Biber J, Murer H, Unwin RJ, Debnam ES. Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice. Exp Physiol 91: 531-537, 2006.
81. Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242: 626-630, 1998. (Pubitemid 28412578)
82. Matsuo A, Negoro T, Seo T, Kitao Y, Shindo M, Segawa H, Miyamoto K. Inhibitory effect of JTP-59557, a new triazole derivative, on intestinal phosphate transport in vitro and in vivo. Eur J Pharmacol 517: 111-119, 2005.
83. Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H. Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial 9: 331-335, 2005. (Pubitemid 41800804)
84. Miyamoto K, Ito M, Tatsumi S, Kuwahata M, Segawa H. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol 27: 503-515, 2007.
85. Murer H, Forster I, Biber J. The sodium phosphate cotransporter family SLC34. Pflügers Arch 447: 763-767, 2004.
86. i transporter in the proximal tubule. Annu Rev Physiol 65: 531-542, 2003.
87. Murer H, Hernando N, Forster I, Biber J. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 80: 1373-1409, 2000.
88. Murer H, Hernando N, Forster L, Biber J. Molecular mechanisms in proximal tubular and small intestinal phosphate reabsorption (plenary lecture). Mol Membr Biol 18: 3-11, 2001.
89. Nafidi O, Lapointe RW, Lepage R, Kumar R, D'Amour P. Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia. Ann Surg 249: 824-827, 2009.
90. Nafidi O, Lepage R, Lapointe RW, D'Amour P. Hepatic resectionrelated hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg 245: 1000-1002, 2007.
91. Nakatani T, Ohnishi M, Razzaque MS. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J 23: 3702-3711, 2009.
92. Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J 23: 433-441, 2009.
93. Nowik M, Picard N, Stange G, Capuano P, Tenenhouse HS, Biber J, Murer H, Wagner CA. Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption. Pflügers Arch 457: 539-549, 2008.
94. O'Riordan DK, Sharp P, Sykes RM, Srai SK, Epstein O, Debnam ES. Cellular mechanisms underlying the increased duodenal iron absorption in rats in response to phenylhydrazine-induced haemolytic anaemia. Eur J Clin Invest 25: 722-727, 1995.
95. Ogbureke KU, Fisher LW. Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int 68: 155-166, 2005.
96. Onishi T, Bone HG, III, Catherwood BD, Deftos LJ. A rat model for hormone and mineral changes in chronic renal failure. Proc Soc Exp Biol Med 174: 193-197, 1983. (Pubitemid 14228181)
97. Page K, Bergwitz C, Jaureguiberry G, Harinarayan CV, Insogna K. A patient with hypophosphatemia, a femoral fracture, and recurrent kidney stones: report of a novel mutation in SLC34A3. Endocr Pract 14: 869-874, 2008.
98. +-dependent phosphate absorption. Am J Physiol Gastrointest Liver Physiol 283: G848-G855, 2002.
99. +-dependent phosphate uptake by phosphophloretin derivatives. Biochem Biophys Res Commun 301: 8-12, 2003.
100. Peerce BE, Peerce B, Clarke RD. Phosphophloretin sensitivity of rabbit renal NaPi-IIa and NaPi-Ia. Am J Physiol Renal Physiol 286: F955-F964, 2004.
101. Peerce BE, Weaver L, Clarke RD. Effect of 2′-phosphophloretin on renal function in chronic renal failure rats. Am J Physiol Renal Physiol 287: F48-F56, 2004.
102. Persy VP, Behets GJ, Bervoets AR, De Broe ME, D'Haese PC. Lanthanum: a safe phosphate binder. Semin Dial 19: 195-199, 2006.
103. Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, que-Blanchet F, Silve C, Grandchamp B, Friedlander G. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347: 983-991, 2002.
104. Prie D, Urena TP, Friedlander G. Latest findings in phosphate homeostasis. Kidney Int 75: 882-889, 2009.
105. i cotransporter in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 288: G496-G500, 2005.
106. i cotransporters in the absence of GABARAP. Pflügers Arch 460: 201-217, 2010.
107. Rowe PS. The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med 15: 264-281, 2004.
108. Rowe PS, Kumagai Y, Gutierrez G, Garrett IR, Blacher R, Rosen D, Cundy J, Navvab S, Chen D, Drezner MK, Quarles LD, Mundy GR. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 34: 303-319, 2004.
109. Sabbagh Y, O'Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC. Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol 20: 2348-2358, 2009.
110. +-dependent phosphate co-transport activity and 1alpha, 25-dihydroxyvitamin D3 production. J Biol Chem 278: 2206-2211, 2003.
111. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N. Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280: 2543-2549, 2005.
112. i cotransporter. J Biol Chem 277: 19665-19672, 2002.
113. i cotransporter adaptation to dietary Pi content in vitamin D receptor null mice. Am J Physiol Renal Physiol 287: F39-F47, 2004.
114. i transporter. Pflügers Arch 446: 585-592, 2003.
115. Segawa H, Onitsuka A, Furutani J, Kaneko I, Aranami F, Matsumoto N, Tomoe Y, Kuwahata M, Ito M, Matsumoto M, Li M, Amizuka N, Miyamoto K. Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development. Am J Physiol Renal Physiol 297: F671-F678, 2009.
116. Segawa H, Onitsuka A, Kuwahata M, Hanabusa E, Furutani J, Kaneko I, Tomoe Y, Aranami F, Matsumoto N, Ito M, Matsumoto M, Li M, Amizuka N, Miyamoto K. Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol 20: 104-113, 2009.
117. i cotransporter in response to a high-phosphate diet. Am J Physiol Renal Physiol 288: F587-F596, 2005.
118. Shaikh A, Berndt T, Kumar R. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr Nephrol 23: 1203-1210, 2008.
119. Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 44: 250-256, 2004. (Pubitemid 38962552)
120. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19: 429-435, 2004.
121. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113: 561-568, 2004.
122. Shimada T, Urakawa I, Yamazaki Y, Hasegawa H, Hino R, Yoneya T, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314: 409-414, 2004.
123. Shimada T, Yamazaki Y, Takahashi M, Hasegawa H, Urakawa I, Oshima T, Ono K, Kakitani M, Tomizuka K, Fujita T, Fukumoto S, Yamashita T. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 289: F1088-F1095, 2005. (Pubitemid 41447065)
124. Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, Nakaya Y, Takeda E. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 20: 1504-1512, 2009.
125. Sinha J, Chen F, Miloh T, Burns RC, Yu Z, Shneider BL. β-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. Am J Physiol Gastrointest Liver Physiol 295: G996-G1003, 2008.
126. i cotransporter NaPi-IIb in small intestine. Am J Physiol Gastrointest Liver Physiol 288: G501-G506, 2005.
127. Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi A, Oka S, Imamura T. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol Endocrinol 22: 1006-1014, 2008.
128. Takahashi Y, Tanaka A, Nakamura T, Fukuwatari T, Shibata K, Shimada N, Ebihara I, Koide H. Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 65: 1099-1104, 2004. (Pubitemid 38251086)
129. Tenenhouse HS, Martel J, Gauthier C, Segawa H, Miyamoto K. Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c. Am J Physiol Renal Physiol 285: F1271-F1278, 2003.
130. Thumfart J, Jung S, Amasheh S, Kramer S, Peters H, Sommer K, Biber J, Murer H, Meij I, Querfeld U, Wagner CA, Muller D. Magnesium stimulates renal phosphate reabsorption. Am J Physiol Renal Physiol 295: F1126-F1133, 2008.
131. Tomoe Y, Segawa H, Shiozawa K, Kaneko I, Tominaga R, Hanabusa E, Aranami F, Furutani J, Kuwahara S, Tatsumi S, Matsumoto M, Ito M, Miyamoto KI. Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice. Am J Physiol Renal Physiol 298: F1341-F1350, 2010.
132. i cotransporter by PTH: immunogold electron microscopy. Am J Physiol Renal Physiol 278: F148-F154, 2000.
133. Villa-Bellosta R, Barac-Nieto M, Breusegem SY, Barry NP, Levi M, Sorribas V. Interactions of the growth-related, type IIc renal sodium/phosphate cotransporter with PDZ proteins. Kidney Int 73: 456-464, 2008.
134. i. Am J Physiol Renal Physiol 296: F691-F699, 2009.
135. Villa-Bellosta R, Sorribas V. Role of rat sodium/phosphate cotransporters in the cell membrane transport of arsenate. Toxicol Appl Pharmacol 232: 125-134, 2008.
136. i deprivation and acidosis. Pflügers Arch 459: 499-508, 2010.
137. Virkki LV, Biber J, Murer H, Forster IC. Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol 293: F643-F654, 2007. (Pubitemid 47403335)
138. Virkki LV, Forster IC, Hernando N, Biber J, Murer H. Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa. J Bone Miner Res 18: 2135-2141, 2003.
139. Wagner CA, Biber J, Murer H. Of men and mice: who is in control of renal phosphate reabsorption?. J Am Soc Nephrol 19: 1625-1626, 2008.
140. 3 metabolites. Am J Physiol Endocrinol Metab Gastrointest Physiol 233: E488-E494, 1977.
141. Walton J, Gray TK. Absorption of inorganic phosphate in the human small intestine. Clin Sci (Lond) 56: 407-412, 1979. (Pubitemid 10156571)
142. White KE, Larsson TE, Econs MJ. The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 27: 221-241, 2006.
143. Williams KB, DeLuca HF. Characterization of intestinal phosphate absorption using a novel in vivo method. Am J Physiol Endocrinol Metab 292: E1917-E1921, 2007.
144. Wrong O, Harland C. Sevelamer and other anion-exchange resins in the prevention and treatment of hyperphosphataemia in chronic renal failure. Nephron Physiol 107: 17-33, 2007.
145. 3. Am J Physiol Cell Physiol 282: C487-C493, 2002.
146. i-IIb gene promoter by epidermal growth factor. Am J Physiol Cell Physiol 280: C628-C636, 2001.
147. Xu H, Inouye M, Hines ER, Collins JF, Ghishan FK. Transcriptional regulation of the human NaPi-IIb cotransporter by EGF in Caco-2 cells involves c-myb. Am J Physiol Cell Physiol 284: C1262-C1271, 2003.
148. Xu H, Uno JK, Inouye M, Xu L, Drees JB, Collins JF, Ghishan FK. Regulation of intestinal NaPi-IIb cotransporter gene expression by estrogen. Am J Physiol Gastrointest Liver Physiol 285: G1317-G1324, 2003. (Pubitemid 37449020)